EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Therapeutic optimization against bacteria carrying metalloenzymes: the battle for class B

Manuel Pina-Sánchez iD, Marta Rua iD, Francisco Javier Candel iD, José Luis Del Pozo iD

Revista Española de Quimioterapia · 2025

DOI: 10.37201/req/s01.08.2025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Revista Española de Quimioterapia, 2025. Verfasst von Manuel Pina-Sánchez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Clínica Universidad de Navarra, Pamplona, Spain. Hauptthemen laut MEDLINE: beta-Lactamases, Anti-Bacterial Agents, Gram-Negative Bacterial Infections, Gram-Negative Bacteria. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The spread of metallo-β-lactamases (MBL)-producing Gram-negative bacilli represents a global health challenge, associated with increased mortality rates. The prevalence of MBL-producing isolates, particularly of New Delhi metallo-β-lactamase (NDM) subclass, is increasing globally. The optimal antibiotic for infections depends on the species and MBL subclass produced. Currently, the antimicrobial cornerstones against these pathogens are aztreonam/avibactam and cefiderocol. Successful therapy requires the early and adequate initiation of antibiotic treatment, optimisation of its pharmacokinetics/pharmacodynamics, and appropriate control of the infection source.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesAnti-Bacterial AgentsGram-Negative Bacterial InfectionsGram-Negative BacteriaHumansCefiderocolCephalosporinsAztreonam

Stichwörter der Autor:innen

Aztreonam/avibactamCarbapenem resistanceCefiderocolGram-negative bacteriaMBL inhibitorsMetallo-β-lactamase

Substanzen

beta-LactamasesAnti-Bacterial AgentsCefiderocolCephalosporinsAztreonam

Autor:innen und Institutionen

  • Department of Clinical Microbiology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Clinical Microbiology and Infectious Diseases. IdISSC & IML Health Research Institutes. Hospital Clínico Universitario San Carlos, Madrid. Spain.
  • Infectious Diseases Division, Clínica Universidad de Navarra, Pamplona, Spain. jdelpozo@unav.es.

ORCID-Profile: Manuel Pina-Sánchez, Marta Rua, Francisco Javier Candel, José Luis Del Pozo

Zitieren

APA

Pina-Sánchez, M., Rua, M., Candel, F. J., & Del Pozo, J. L. (2025). Therapeutic optimization against bacteria carrying metalloenzymes: the battle for class B. Revista Española de Quimioterapia. https://doi.org/10.37201/req/s01.08.2025

Vancouver

Pina-Sánchez M, Rua M, Candel FJ, Del Pozo JL. Therapeutic optimization against bacteria carrying metalloenzymes: the battle for class B. Revista Española de Quimioterapia. 2025. doi:10.37201/req/s01.08.2025

BibTeX
@article{PinaSnchez2025,
  author = {Pina-Sánchez, Manuel and Rua, Marta and Candel, Francisco Javier and Del Pozo, José Luis},
  title = {Therapeutic optimization against bacteria carrying metalloenzymes: the battle for class B},
  journal = {Revista Española de Quimioterapia},
  year = {2025},
  doi = {10.37201/req/s01.08.2025}
}
Kostenlos starten →